Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
clinical trials
life sciences
national blog main
national top stories
new york blog main
4
×
new york top stories
drugs
fda
new york
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
abbvie
acorda therapeutics
allergan
allopregnanolone
ampyra
apokyn
apomorphine
blueprint medicines
boston
boulder/denver blog main
boulder/denver top stories
brexanolone
bristol-myers squibb
cancer
clinical data
companion diagnostic
dalfampridine
detroit blog main
detroit top stories
dna sequencing
duopa
entrectinib
express scripts
foundation medicine
genfit
What
approved
4
×
drug
4
×
new
4
×
fda
medicine
disease
oks
acorda
brexanolone
cancer
cope
data
deeper
depression
devastating
disorder
dna
episodes
fast
fatty
fingerprint
friday
genetic
gets
going
help
horizon
intercept
known
late
liver
looms
marketed
matter
meant
medications
moms
nash
nd
nod
Language
Current search:
drug
×
new
×
" new york blog main "
×
approved
×
@xconomy.com
5 years ago
FDA OKs Depression Drug For New Moms: Fast Relief But Tough to Take
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Genetic Medicine: FDA OKs 2nd Cancer Drug that Targets DNA, not Tissues